NFL puts more funding into CBD studies.
The National Football League and the NFL Players Association (NFLPA) announced that they will put just over half a million dollars into two studies to explore “first-of-their-kind, alternative pain management methods that could benefit NFL players, and society at large,” one of which includes CBD.
The American Society of Pain and Neuroscience study will look into “the effects of cannabidiol (CBD) and non-invasive vagal nerve stimulation (nVNS) on alleviating concussion symptoms.”
This isn’t the first time the NFL has explored the potential of cannabinoids. Last year, as Cannabis Wire reported at the time, the NFL gave $1 million to the University of California San Diego and the University of Regina to study “the effects of cannabinoids on pain management.”
“We are proud to lead the way on investigating how the use of CBD and other alternative measures could positively impact pain management for players,” said Allen Sills, NFL Chief Medical Officer, in this week’s announcement. “As within the broader scope of player health and safety, we want to ensure every treatment at our disposal clears the appropriate medical standard for wider use.”
Connecticut awards first Community Reinvestment Pilot Program grants.
The Connecticut Social Equity Council awarded $6 million from the state’s adult use program to 6 organizations in the state to “uplift communities and strengthen families disproportionately impacted by the ‘War on Drugs.’”
The entities, which got $1 million each, are:
• Neighborhood Housing Services of Waterbury
• United Way of Western CT
• The Community Foundation of Eastern Connecticut
• The Prosperity Foundation
• United Way of Coastal Fairfield County
• The Hispanic Federation
“We are excited to give back to communities affected for so long by the failed war on drugs,” said SEC executive director Ginne-Rae Clay in the announcement.
“This pilot program and first round of funding is intended to have a direct and immediate benefit [to] communities and residents that are most vulnerable, our youth who are really struggling right now, and the reentry population who have probably been harmed the most.”
Oklahoma has 32x more medical cannabis than it needs.
That is according to a supply-and-demand study commissioned by the Oklahoma Medical Marijuana Authority and conducted by Cannabis Public Policy Consulting.
The 21-page study, released Thursday, suggests that this “exponential” oversupply is likely driving the state’s robust unlicensed market, much of which is headed out of state.
“It is essential that we address this oversupply head-on, not only to ensure the integrity and sustainability of our medical marijuana market for our patients but to promote public safety and mitigate dangers that coincide with illicit marijuana activity for all Oklahomans,” said OMMA executive director Adria Berry in the announcement.